<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10174702</article-id>
    <article-id pub-id-type="pmid">37104749</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btad290</article-id>
    <article-id pub-id-type="publisher-id">btad290</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CNV-ClinViewer: enhancing the clinical interpretation of large copy-number variants online</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4217-5277</contrib-id>
        <name>
          <surname>Macnee</surname>
          <given-names>Marie</given-names>
        </name>
        <aff><institution>Cologne Center for Genomics (CCG), University of Cologne</institution>, Cologne, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0546-5141</contrib-id>
        <name>
          <surname>Pérez-Palma</surname>
          <given-names>Eduardo</given-names>
        </name>
        <aff><institution>Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana</institution>, Santiago, <country country="CL">Chile</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brünger</surname>
          <given-names>Tobias</given-names>
        </name>
        <aff><institution>Cologne Center for Genomics (CCG), University of Cologne</institution>, Cologne, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Klöckner</surname>
          <given-names>Chiara</given-names>
        </name>
        <aff><institution>Institute of Human Genetics, University of Leipzig Medical Center</institution>, Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6127-6308</contrib-id>
        <name>
          <surname>Platzer</surname>
          <given-names>Konrad</given-names>
        </name>
        <aff><institution>Institute of Human Genetics, University of Leipzig Medical Center</institution>, Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stefanski</surname>
          <given-names>Arthur</given-names>
        </name>
        <aff><institution>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
        <aff><institution>Epilepsy Center, Neurological Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Montanucci</surname>
          <given-names>Ludovica</given-names>
        </name>
        <aff><institution>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bayat</surname>
          <given-names>Allan</given-names>
        </name>
        <aff><institution>Department of Epilepsy Genetics and Personalized Medicine, Member of ERN Epicare, Danish Epilepsy Centre</institution>, Dianalund, <country country="DK">Denmark</country></aff>
        <aff><institution>Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark</institution>, Odense, <country country="DK">Denmark</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Radtke</surname>
          <given-names>Maximilian</given-names>
        </name>
        <aff><institution>Institute of Human Genetics, University of Leipzig Medical Center</institution>, Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1268-9995</contrib-id>
        <name>
          <surname>Collins</surname>
          <given-names>Ryan L</given-names>
        </name>
        <aff><institution>Broad Institute of Massachusetts Institute of Technology and Harvard</institution>, Cambridge, MA, <country country="US">USA</country></aff>
        <aff><institution>Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Talkowski</surname>
          <given-names>Michael</given-names>
        </name>
        <aff><institution>Broad Institute of Massachusetts Institute of Technology and Harvard</institution>, Cambridge, MA, <country country="US">USA</country></aff>
        <aff><institution>Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6833-9049</contrib-id>
        <name>
          <surname>Blankenberg</surname>
          <given-names>Daniel</given-names>
        </name>
        <aff><institution>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Møller</surname>
          <given-names>Rikke S</given-names>
        </name>
        <aff><institution>Department of Epilepsy Genetics and Personalized Medicine, Member of ERN Epicare, Danish Epilepsy Centre</institution>, Dianalund, <country country="DK">Denmark</country></aff>
        <aff><institution>Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark</institution>, Odense, <country country="DK">Denmark</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4435-6610</contrib-id>
        <name>
          <surname>Lemke</surname>
          <given-names>Johannes R</given-names>
        </name>
        <aff><institution>Institute of Human Genetics, University of Leipzig Medical Center</institution>, Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nothnagel</surname>
          <given-names>Michael</given-names>
        </name>
        <aff><institution>Cologne Center for Genomics (CCG), University of Cologne</institution>, Cologne, <country country="DE">Germany</country></aff>
        <aff><institution>University Hospital Cologne</institution>, Cologne, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8698-3770</contrib-id>
        <name>
          <surname>May</surname>
          <given-names>Patrick</given-names>
        </name>
        <aff><institution>Luxembourg Centre for Systems Biomedicine, University Luxembourg</institution>, Esch-sur-Alzette, <country country="LU">Luxembourg</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5173-9636</contrib-id>
        <name>
          <surname>Lal</surname>
          <given-names>Dennis</given-names>
        </name>
        <aff><institution>Cologne Center for Genomics (CCG), University of Cologne</institution>, Cologne, <country country="DE">Germany</country></aff>
        <aff><institution>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
        <aff><institution>Epilepsy Center, Neurological Institute, Cleveland Clinic</institution>, Cleveland, OH, <country country="US">USA</country></aff>
        <aff><institution>Broad Institute of Massachusetts Institute of Technology and Harvard</institution>, Cambridge, MA, <country country="US">USA</country></aff>
        <xref rid="btad290-cor1" ref-type="corresp"/>
        <!--lald@ccf.org-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Kendziorski</surname>
          <given-names>Christina</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btad290-cor1">Corresponding author. Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany. E-mail: <email>lald@ccf.org</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-04-27">
      <day>27</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>27</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <volume>39</volume>
    <issue>5</issue>
    <elocation-id>btad290</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>6</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>13</day>
        <month>2</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>26</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>11</day>
        <month>5</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btad290.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Pathogenic copy-number variants (CNVs) can cause a heterogeneous spectrum of rare and severe disorders. However, most CNVs are benign and are part of natural variation in human genomes. CNV pathogenicity classification, genotype–phenotype analyses, and therapeutic target identification are challenging and time-consuming tasks that require the integration and analysis of information from multiple scattered sources by experts.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>Here, we introduce the CNV-ClinViewer, an open-source web application for clinical evaluation and visual exploration of CNVs. The application enables real-time interactive exploration of large CNV datasets in a user-friendly designed interface and facilitates semi-automated clinical CNV interpretation following the ACMG guidelines by integrating the ClassifCNV tool. In combination with clinical judgment, the application enables clinicians and researchers to formulate novel hypotheses and guide their decision-making process. Subsequently, the CNV-ClinViewer enhances for clinical investigators’ patient care and for basic scientists’ translational genomic research.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The web application is freely available at <ext-link xlink:href="https://cnv-ClinViewer.broadinstitute.org" ext-link-type="uri">https://cnv-ClinViewer.broadinstitute.org</ext-link> and the open-source code can be found at <ext-link xlink:href="https://github.com/LalResearchGroup/CNV-clinviewer" ext-link-type="uri">https://github.com/LalResearchGroup/CNV-clinviewer</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Federal Ministry for Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>01GM1907D</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>One of the reasons for genetic disorders is copy-number changes of one or more genes, resulting from deletions, duplications, or other genomic rearrangements. Most disease-associated CNVs are unique, cause severe complex disorders, and are often hard to distinguish from benign CNVs frequently found in the general population (<xref rid="btad290-B22" ref-type="bibr">Riggs et al. 2020</xref>).</p>
    <p>Although the average size of pathogenic/likely pathogenic CNVs in ClinVar (<xref rid="btad290-B16" ref-type="bibr">Landrum et al. 2018</xref>) of 9.7 Mb (95% CI 9.3–10.1 Mb, median = 2.6 Mb) is likely overestimated due to frequent imprecise discovery of CNVs with arrays, disease-associated CNVs typically cover tens to hundreds of genes. Thus, pinpointing the underlying disease driver and modifier genes represents a major challenge. Given the complexity of CNV interpretation, the American College of Medical Genetics and Genomics (ACMG) has developed technical standards (a quantitative, evidence-based scoring framework) to standardize the evaluation process of the genomic content of a CNV region, and to promote consistency and transparency in classification and reporting across clinical laboratories (<xref rid="btad290-B22" ref-type="bibr">Riggs et al. 2020</xref>). The application of those standards involves clinical and genetic CNV data that are scattered across registries, databases, and the literature. Therefore, it is difficult and highly time-consuming to annotate, analyze, and interpret CNVs manually in a clinical setting.</p>
    <p>Several bioinformatics tools, often fully-automated, have been developed for clinicians and researchers to facilitate large-scale CNV classification according to the ACMG guidelines (for example see (<xref rid="btad290-B10" ref-type="bibr">Geoffroy et al. 2018</xref>, <xref rid="btad290-B12" ref-type="bibr">Gurbich and Ilinsky 2020</xref>, <xref rid="btad290-B21" ref-type="bibr">Requena et al. 2021</xref>). However, no algorithm or even classification framework can perfectly capture data, i.e. usually only available to experts, such as deep clinical, CNV, or gene-level information. This specifically affects data that cannot be extracted from public online resources, such as detailed information about the phenotype, including family history, CNV inheritance pattern, and many other criteria currently not integrated in the clinical significance classification. For the semi-automated tools (<xref rid="btad290-B8" ref-type="bibr">Fan et al. 2021</xref>), the extracted and manually entered information is not explorable within the same web-application interface and comparative visual inspection of CNVs with various genomic and clinical data sources is not possible because current tools do not provide such functionality (<xref rid="btad290-B10" ref-type="bibr">Geoffroy et al. 2018</xref>, <xref rid="btad290-B12" ref-type="bibr">Gurbich and Ilinsky 2020</xref>, <xref rid="btad290-B8" ref-type="bibr">Fan et al. 2021</xref>, <xref rid="btad290-B21" ref-type="bibr">Requena et al. 2021</xref>). While the current focus of those existing tools is on clinical significance classification, they are not designed to perform ad-hoc evaluations of new data such as genotype–phenotype analyses to expose undiscovered patterns of CNV localization in patient cohorts. To show a correlation of patient CNVs with known disease genes at a specific locus or to narrow down dosage-sensitive genes that are likely driver genes in particular CNVs, the interactive visual inspection of affected genomic content combined with crosslinked data from various sources can enhance the interpretational analysis of CNVs. Paradoxically, the individuals who collect the most relevant clinical information for CNV clinical significance classification and interpretation, such as genetic counselors, treating physicians, and patients’ families, often lack the required bioinformatical expertise to examine several patient CNVs simultaneously and integrate information from multiple scattered sources time-efficiently. To overcome current limitations for biomedical CNV interpretation of those individuals and researchers, we developed the CNV-ClinViewer, a fully open-source exploration and interpretation platform that integrates analysis, annotation, guideline based, classification and clinical evaluation of CNVs and provides users, even families with CNVs of uncertain significance, with an interface to curate, visualize, interact with, and continuously re-evaluate the CNV data.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>Details about the data sources used in the CNV-ClinViewer can be found in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p>
    <sec>
      <title>2.1 Genetic CNV variants and regions datasets</title>
      <p>CNVs with annotated clinical significance were obtained from ClinVar (<xref rid="btad290-B16" ref-type="bibr">Landrum et al. 2018</xref>) (updated quarterly), and CNVs identified in the general population were obtained from the UK biobank (<xref rid="btad290-B1" ref-type="bibr">Aguirre et al. 2019</xref>) as well as from gnomAD (<xref rid="btad290-B6" ref-type="bibr">Collins et al. 2020</xref>) (controls-only dataset, version 2.1). GnomAD CNVs were reduced to those with a filter equal to PASS, and SVTYPE equivalent to “DEL” or “DUP”, and all CNVs from the general population were filtered for large CNVs &gt;50 kb. Specifically, we collected 52 344 CNVs from ClinVar (10 654 pathogenic/likely pathogenic CNVs), 195 916 CNVs from the UK-biobank (&gt;50 kb), and 10 370 CNVs from gnomAD (&gt;50 kb). The genome coordinates of CNVs from the UK biobank and gnomAD were converted to GRCh38 using the UCSC LiftOver tool (<xref rid="btad290-B13" ref-type="bibr">Kent et al. 2002</xref>, <xref rid="btad290-B22" ref-type="bibr">Riggs et al. 2020</xref>).</p>
      <p>To annotate neutral as well as clinically relevant regions by use of a visual summary of the variants, we further processed the variants by counting the number of deletions or duplications in the different datasets using a sliding window approach with a window size of 200 kb and step size of 100 kb. For the cohort-level data from the UK-biobank and gnomAD, we divided the counts by the number of samples in the cohort to retrieve region-specific allele frequencies.</p>
      <p>Known CNV syndromes and genomic regions with evaluated dosage sensitivity were obtained from DECIPHER (<xref rid="btad290-B9" ref-type="bibr">Firth et al. 2009</xref>) and ClinGen (<xref rid="btad290-B20" ref-type="bibr">Rehm et al. 2015</xref>) (updated quarterly) databases.</p>
    </sec>
    <sec>
      <title>2.2 Gene-level annotations</title>
      <p>We retrieved a list of 18 792 protein-coding gene symbols from the HUGO Gene Nomenclature Committee (HGNC) (<xref rid="btad290-B24" ref-type="bibr">Tweedie et al. 2021</xref>). These genes were annotated by genomic boundaries of one transcript from RefSeq (<xref rid="btad290-B19" ref-type="bibr">O’Leary et al. 2016</xref>) (GRCh37/hg19 and GRCh38/hg38), either the MANE select transcript or alternatively the longest transcript. In addition, we annotated gene-level scores for sequence constraint and dosage sensitivity in humans (<xref rid="btad290-T1" ref-type="table">Table 1</xref>) and gene–disease associations from ClinGen (<xref rid="btad290-B20" ref-type="bibr">Rehm et al. 2015</xref>) (updated quarterly).</p>
      <table-wrap position="float" id="btad290-T1">
        <label>Table 1.</label>
        <caption>
          <p>Description of gene-level scores for sequence constraint and dosage sensitivity<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Category</th>
              <th align="center" rowspan="1" colspan="1">Score</th>
              <th align="center" rowspan="1" colspan="1">Description</th>
              <th align="center" rowspan="1" colspan="1">Threshold</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Sequence constraint score as proxy for haploinsufficiency</td>
              <td rowspan="1" colspan="1">pLI (<xref rid="btad290-B151" ref-type="bibr">Lek et al. 2016</xref>)</td>
              <td rowspan="1" colspan="1">Probability of loss of function intolerance. Genes with high pLI scores are considered more intolerant to protein truncation variations.</td>
              <td rowspan="1" colspan="1">&gt;0.9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Sequence constraint score as proxy for haploinsufficiency</td>
              <td rowspan="1" colspan="1">loeuf (<xref rid="btad290-B152" ref-type="bibr">Karczewski et al. 2020</xref>)</td>
              <td rowspan="1" colspan="1">Loss-of-function observed/expected upper bound fraction. Low LOEUF scores indicate strong selection against predicted loss-of-function (pLoF) variation in a given gene.</td>
              <td rowspan="1" colspan="1">&lt;0.35</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Haploinsufficiency</td>
              <td rowspan="1" colspan="1">pHI (<xref rid="btad290-B153" ref-type="bibr">Collins et al. 2022</xref>)</td>
              <td rowspan="1" colspan="1">Predicted probability of haploinsufficiency of autosomal genes by predictive model from a cross-disorder dosage sensitivity map of the human genome (analysis of rare CNVs from &gt;700k individuals). Genes with high pHI scores are considered more likely triplosensitive.</td>
              <td rowspan="1" colspan="1">&gt;0.833</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Triplosensitivity</td>
              <td rowspan="1" colspan="1">pTS (<xref rid="btad290-B153" ref-type="bibr">Collins et al. 2022</xref>)</td>
              <td rowspan="1" colspan="1">Predicted probability of triplsensitivity of autosomal genes by predictive model from a cross-disorder dosage sensitivity map of the human genome (analysis of rare CNVs from &gt;700k individuals). Genes with high pTS scores are considered more likely triplosensitive.</td>
              <td rowspan="1" colspan="1">&gt;0.993</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Haploinsufficiency</td>
              <td rowspan="1" colspan="1">%HI (<xref rid="btad290-B9" ref-type="bibr">Firth et al. 2009</xref>)</td>
              <td rowspan="1" colspan="1">By DECIPHER (<xref rid="btad290-B9" ref-type="bibr">Firth et al. 2009</xref>) updated predictions of haploinsufficiency as described by (<xref rid="btad290-B154" ref-type="bibr">Huang et al. (2010)</xref>. Genes with high ranks (e.g. 0–10%) indicate a gene is more likely to exhibit haploinsufficiency.</td>
              <td rowspan="1" colspan="1">&lt;10%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Haploinsufficiency</td>
              <td rowspan="1" colspan="1">HI Score ClinGen (<xref rid="btad290-B20" ref-type="bibr">Rehm et al. 2015</xref>)</td>
              <td rowspan="1" colspan="1">The ClinGen Dosage Sensitivity expert group collects evidence supporting/refuting the haploinsufficiency of genes.</td>
              <td rowspan="1" colspan="1">3 (sufficient evidence)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Triplosensitivity</td>
              <td rowspan="1" colspan="1">TS Score ClinGen (<xref rid="btad290-B20" ref-type="bibr">Rehm et al. 2015</xref>)</td>
              <td rowspan="1" colspan="1">The ClinGen Dosage Sensitivity expert group collects evidence supporting/refuting the triplosensitivity of genes.</td>
              <td rowspan="1" colspan="1">3 (sufficient evidence)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn1">
            <label>a</label>
            <p>The given thresholds are used in the CNV-ClinViewer to annotate dosage sensitivity of genes.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>2.3 CNV-ClinViewer web server development</title>
      <p>The CNV-ClinViewer was developed with the Shiny framework of R studio software (v.1.7.1, <ext-link xlink:href="https://shiny.rstudio.com/" ext-link-type="uri">https://shiny.rstudio.com/</ext-link>) which transforms regular R code into an interactive environment that can follow and “react” to remote-user instructions. The pre-processed data alongside the R/Shiny code was uploaded as a stand-alone Ubuntu image with Google Cloud services. The image was deployed into a Google Virtual Machine (VM) using the googleComputeEngineR package (v.0.3.0, <ext-link xlink:href="https://github.com/cloudyr/googleComputeEngineR" ext-link-type="uri">https://github.com/cloudyr/googleComputeEngineR</ext-link>). The CNV-ClinViewer web server (<ext-link xlink:href="https://cnv-ClinViewer.broadinstitute.org/" ext-link-type="uri">https://cnv-ClinViewer.broadinstitute.org/</ext-link>) is compatible with all commonly used Internet browsers.</p>
      <p>For the classification of uploaded CNVs, the clinical interpretation tool ClassifyCNV (<xref rid="btad290-B12" ref-type="bibr">Gurbich and Ilinsky 2020</xref>) including its own data sources was integrated into the CNV-ClinViewer framework. Upon selection of one of the uploaded and classified CNVs, all pre-processed data are intersected by genomic coordinates of the selected CNV. Consequently, the HTML report describing the selected CNV is generated using the rmarkdown R package (v2.11, <ext-link xlink:href="https://rmarkdown.rstudio.com" ext-link-type="uri">https://rmarkdown.rstudio.com</ext-link>), and the interactive visualizations and tables are rendered using the ggplot2 (v.3.3.5, <ext-link xlink:href="https://ggplot2.tidyverse.org" ext-link-type="uri">https://ggplot2.tidyverse.org</ext-link>), plotly (v.4.9.4.1 <ext-link xlink:href="https://plotly-r.com" ext-link-type="uri">https://plotly-r.com</ext-link>), and DT (v.0.19, <ext-link xlink:href="https://CRAN.R-project.org/package=DT" ext-link-type="uri">https://CRAN.R-project.org/package=DT</ext-link>) R packages. For the gene set enrichment analysis, the enrichr R package (v3.0, <ext-link xlink:href="https://CRAN.R-project.org/package=enrichR" ext-link-type="uri">https://CRAN.R-project.org/package=enrichR</ext-link>) that provides an interface to the Enrichr database is used.</p>
      <p>The CNV-ClinViewer is an open-source project, and its code will continue to grow and improve through version control in the GitHub repository (<ext-link xlink:href="https://github.com/LalResearchGroup/CNV-clinviewer" ext-link-type="uri">https://github.com/LalResearchGroup/CNV-clinviewer</ext-link>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>We present the CNV-ClinViewer, a user-friendly web application that semi-automatedly enhances the ACMG guideline-based CNV classification (<xref rid="btad290-B15" ref-type="bibr">Kuleshov et al. 2016</xref>) for caregivers and facilitates the biomedical interpretation of gene content at a locus of interest for scientists. Development, workflow, and main features are presented in <xref rid="btad290-F1" ref-type="fig">Fig. 1</xref>.</p>
    <fig position="float" id="btad290-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Development and use of CNV-ClinViewer. CNV data as well as clinical and genomic annotations are collected, processed and annotated, and quarterly updated. Users can copy-paste CNV(s) or upload CNVs in a tab-separated or Excel file for real-time exploration and interpretation.</p>
      </caption>
      <graphic xlink:href="btad290f1" position="float"/>
    </fig>
    <sec>
      <title>3.1 Upload of one up to thousands of CNVs for clinical interpretation and genetic reports</title>
      <p>The CNV-ClinViewer allows simultaneous analysis of single or multiple CNVs, irrespective of the technology used to identify them. It requires as input the genomic coordinates of CNVs based on the human reference genome GRCh37/hg19 (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/data-hub/genome/GCF_000001405.13/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/data-hub/genome/GCF_000001405.13/</ext-link>) or GRCh38/hg38 (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/data-hub/genome/GCF_000001405.40/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/data-hub/genome/GCF_000001405.40/</ext-link>), either by copy-pasting or by uploading a tab-separated text or Excel file (max. number of CNVs = 10 000). Minimal required information for each CNV, including whole chromosome trisomies and monosomies, is the chromosome, start, end, and CNV type (deletion or duplication). Optionally, the user can provide sample IDs, phenotype information for filtering and a score of manually assessed evidence categories of the 2019 ACMG standard guidelines (see below). Details and example files can be found in the help section and on the about page of the CNV-ClinViewer.</p>
      <p>After CNV submission, the user is directed to the analysis interface. Here, five different analysis panels are available. In the <italic toggle="yes">first analysis panel</italic>, the uploaded CNVs are displayed in a downloadable table comprising their annotated clinical significance and details about the scoring (<xref rid="btad290-F2" ref-type="fig">Fig. 2A</xref>). The CNVs are classified by ClassifyCNV (<xref rid="btad290-B12" ref-type="bibr">Gurbich and Ilinsky 2020</xref>), a command-line tool integrated into the CNV-ClinViewer infrastructure that automatically evaluates the evidence categories 1A/B, 2A–H, 3A–C, 4O for copy-number losses and 1A/B, 2A–H, 2J–L, 3A–C, 4O for copy-number gains from the 2019 ACMG/ClinGen Technical Standards for CNVs (<xref rid="btad290-B22" ref-type="bibr">Riggs et al. 2020</xref>). In case the user uploaded additional scores of relevant ACMG clinical significance criteria for which additional information, such as family history or the <italic toggle="yes">de novo</italic> status, is required, the score is added to the score from ClassifyCNV to refine the final score and classification. In the <italic toggle="yes">second analysis panel</italic>, a comprehensive report of the individual CNVs can be downloaded (<xref rid="btad290-F2" ref-type="fig">Fig. 2B</xref>). The report includes details about the clinical significance classification and the overlap with established/predicted haploinsufficient/triplosensitive and clinically relevant genes and genomic regions<underline>.</underline></p>
      <fig position="float" id="btad290-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Semi-automated classification and download of CNV reports. (<bold>A</bold>) The integrated semi-automated classification of uploaded CNVs is based on 2019 ACMG/ClinGen Technical Standards for CNVs by ClassifyCNV<sup>3</sup> and is one of the key features of the CNV-ClinViewer. The resulting scores and applied evidence categories can be inspected in a table overview and also downloaded. (<bold>B</bold>) A comprehensive report on individual CNVs, including details about the clinical significance classification and the overlap with established/predicted haploinsufficient/triplosensitive and clinically relevant genes and genomic regions, can be downloaded.</p>
        </caption>
        <graphic xlink:href="btad290f2" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.2 Uploaded CNV data can be visually inspected alongside publicly available data</title>
      <p>The <italic toggle="yes">third panel</italic> of the analysis interface is a genomic viewer (<xref rid="btad290-F3" ref-type="fig">Fig. 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1A</xref>–F). Here, the uploaded CNVs and their genomic region can be inspected alongside biomedical annotations and other pathogenic and general population CNV datasets. Included are five data tracks that the user can interactively navigate by zooming in/out, moving horizontally, and selecting genomic regions of interest. In the first track of the genomic viewer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1B</xref>), the CNV-ClinViewer integrates seamless evaluation of the gene content by visualization of all protein-coding genes. Here, the genes are highlighted by a selection of gene dosage sensitivity scores (<xref rid="btad290-T1" ref-type="table">Table 1</xref>) to enable fast and visual gene prioritization in context to the uploaded CNVs. Below this gene track, all uploaded CNVs that intersect the selected region are visualized and can be interactively filtered based on uploaded phenotypic annotations, their assigned clinical significance, CNV type, and sample IDs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1C</xref>). The further tracks enable the visual identification of disease-prone regions with coupled visualizations of summarized data (allele frequencies and allele counts) of more than 250 000 CNVs from the general population [UK Biobank (<xref rid="btad290-B1" ref-type="bibr">Aguirre et al. 2019</xref>), gnomAD (<xref rid="btad290-B6" ref-type="bibr">Collins et al. 2020</xref>)], and pathogenic/likely pathogenic CNVs from ClinVar (<xref rid="btad290-B16" ref-type="bibr">Landrum et al. 2018</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1D</xref>–F). In addition, users can identify the overlap of uploaded CNVs with individual ClinVar CNVs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1D</xref>). The latter are displayed in an interactive plot grouped by their assigned clinical significance (pathogenic/likely pathogenic versus uncertain significance versus benign/likely benign) and can be filtered based on their type and clinical significance. Details about the ClinVar CNVs, such as their reported phenotypes or allele origin and the link to the ClinVar variant website, are shown in a table and can be downloaded for further analyses.</p>
      <fig position="float" id="btad290-F3">
        <label>Figure 3.</label>
        <caption>
          <p>Genomic viewer. A genomic viewer allows inspecting the uploaded CNVs and their genomic region alongside biomedical annotations and other pathogenic and general population CNV datasets. Here, the user can visually compare and dynamically filter uploaded CNVs, perform a seamless evaluation of the gene content, identify disease-prone regions and find unknown patterns of CNV localization to generate hypotheses for further research. An extended view of the genomic viewer can be found in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>.</p>
        </caption>
        <graphic xlink:href="btad290f3" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.3 Additional features and analyses provide users with advanced CNV insights</title>
      <p>Below the genomic viewer, the user can retrieve and download information about the intersecting genes, classified gene–disease associations from ClinGen (<xref rid="btad290-B20" ref-type="bibr">Rehm et al. 2015</xref>), known dosage-sensitive regions and CNV syndromes (<xref rid="btad290-F4" ref-type="fig">Fig. 4A</xref>). The gene table contains all protein-coding genes, their genomic coordinates and transcript IDs, links to the Online Mendelian Inheritance in Man database (OMIM, <ext-link xlink:href="https://omim.org/" ext-link-type="uri">https://omim.org/</ext-link>), and gene dosage sensitivity scores (<xref rid="btad290-T1" ref-type="table">Table 1</xref>). All genes classified by ClinGen with reported associations with one or several diseases are shown in the gene–disease association table, including links to the comprehensive gene–disease association reports on the ClinGen website. In the ClinGen region table and the DECIPHER (<xref rid="btad290-B9" ref-type="bibr">Firth et al. 2009</xref>) CNV syndrome table, all well-characterized dosage sensitive regions and developmental CNV syndromes that intersect a CNV/genomic region of interest can be retrieved.</p>
      <fig position="float" id="btad290-F4">
        <label>Figure 4.</label>
        <caption>
          <p>Additional features. (<bold>A</bold>) Users can retrieve, filter, and download information about the intersecting genes, gene–disease associations, known dosage sensitive regions, and known CNV syndromes. (<bold>B</bold>) Users can perform gene-set enrichment analyses (GSEA) to infer information on genes within a selected genomic region or CNV by comparing it to &gt;180 annotated gene sets representing prior biological knowledge such as pathways, Human Phenotype Ontology (HPO) terms, and known (rare) diseases.</p>
        </caption>
        <graphic xlink:href="btad290f4" position="float"/>
      </fig>
      <p>In the last panel, the user can perform gene set enrichment analyses to infer knowledge about the genes from a selected genomic region by comparing it to more than 180 annotated gene sets representing prior biological knowledge such as pathways, Human Phenotype Ontology (HPO) terms (<xref rid="btad290-B14" ref-type="bibr">Köhler et al. 2021</xref>), and known (rare) diseases (<xref rid="btad290-F4" ref-type="fig">Fig. 4B</xref>).</p>
    </sec>
    <sec>
      <title>3.4 Example analysis: 9q33.3q34.11 microdeletions</title>
      <p>To illustrate the utility of the CNV-ClinViewer, we performed an example analysis of 14 previously published CNVs (9q33.3q34.11 microdeletions) from patients with complex developmental disorders from the literature (<italic toggle="yes">n</italic> = 14) (<xref rid="btad290-B5" ref-type="bibr">Campbell et al. 2012</xref>, <xref rid="btad290-B23" ref-type="bibr">Saitsu et al. 2012</xref>, <xref rid="btad290-B7" ref-type="bibr">Ehret et al. 2015</xref>, <xref rid="btad290-B17" ref-type="bibr">Nambot et al. 2016</xref>). Here, the CNVs were first uploaded and automatically classified as (likely) pathogenic (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S2 and S3</xref>). Next, the smallest region of overlap with its dosage sensitive gene <italic toggle="yes">STXBP1</italic> could be immediately identified due to the interactive visualization of the overlapping patient CNVs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S4 and S5</xref>). In addition, the CNV-ClinViewer could resolve the clinical heterogeneity of patients by enabling the user to filter the CNVs based on assigned phenotypes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>) and retrieve region-specific information about intersecting clinically relevant genes and their associated phenotypes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>) as well as overlapping patient CNVs from ClinVar (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S8</xref>). Overall, we demonstrate the CNV-ClinViewer’s fast and seamless biomedical interpretation of CNVs and its potential to replicate research findings due to a large number of annotations and visual inspection capabilities. To perform a comparable analysis without the CNV-ClinViewer, the user would be required to classify the CNVs manually one at a time or with the support of an existing tool, visualize the CNVs with yet another tool or genomic viewer, visit several webpages, and process and annotate information from various databases. The example analysis, including an example of benign CNVs of chromosome 9, can be found in more detail and with step-by-step instructions illustrated with images in the <xref rid="sup1" ref-type="supplementary-material">Supplementary File</xref>.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>By aggregating more than 250 000 population and patient CNVs, annotating various gene scores and clinical annotations, and integrating useful existing bioinformatics tools, we developed a novel and user-friendly interface as a decision support tool for the clinical evaluation of CNVs and comparative visual inspection.</p>
    <p>CNV analysis and interpretation tools and, in general, clinical decision support tools can make patient care more efficient, cost-effective, and guideline concordant. However, although the prediction results from many approaches are promising, their value is limited by their lack of interpretability and human intuition. The black-box nature of some pathogenicity predictions can further exacerbate trust issues and worsen the overall experience (<xref rid="btad290-B4" ref-type="bibr">Cai et al. 2019</xref>). To address this issue, human-centered tools with interactive mechanisms can grant end-users more agency in guiding the interpretation and can be used for critical decision-making purposes beyond an algorithm (<xref rid="btad290-B4" ref-type="bibr">Cai et al. 2019</xref>, <xref rid="btad290-B2" ref-type="bibr">Babione et al. 2020</xref>). Therefore, in the development of the CNV-ClinViewer, we emphasized interactive analyses of the CNVs beyond a classification score and allow the user to dynamically inspect and compare the results in detail. In comparison, existing open-source tools (<xref rid="btad290-B10" ref-type="bibr">Geoffroy et al. 2018</xref>, <xref rid="btad290-B12" ref-type="bibr">Gurbich and Ilinsky 2020</xref>, <xref rid="btad290-B8" ref-type="bibr">Fan et al. 2021</xref>) focus more on the classification scores than on the interactive inspection and further investigations. We believe that the comprehensive approach of the CNV-ClinViewer will empower users with more trust in the results, the agency to test hypotheses, and enable them to apply their domain knowledge while simultaneously leveraging the benefits of automation.</p>
    <p>To ensure that a tool is easy to use and is designed for target users at each development stage, human-centered design methods and principles should be applied (<xref rid="btad290-B2" ref-type="bibr">Babione et al. 2020</xref>, <xref rid="btad290-B3" ref-type="bibr">Bates et al. 2003</xref>). Such methods draw from well-established design principles in many disciplines, including usability, visualizations, and interface design, and consider users’ context and experience. As the effectiveness of clinical tools may be severely limited without the application of those principles and could even contribute to adverse medical events (<xref rid="btad290-B11" ref-type="bibr">Graham et al. 2008</xref>), we put great emphasis on developing a user-friendly interface with simple data upload with minimal requirements, a clear analysis workflow, and real-time results, while giving the user the ability to retrieve details and help and modify the analysis when required. We also focused on the visual and intuitive inspection of CNV data and its interaction with the user. In particular, for genomic data, the integration of visualizations is essential for interpretation and hypothesis generation, essential for combining different data sources and discovering unexpected localization patterns of genomic annotations in a short amount of time, as well as a valuable aid in communicating discoveries (<xref rid="btad290-B18" ref-type="bibr">Nusrat et al. 2019</xref>).</p>
    <p>On the one hand, the CNV-ClinViewer will assist clinicians, clinical geneticists, and genetic counselors in analyzing and interpreting CNV data and improving objectivity and accuracy in the clinical work-up. On the other hand, the collected and integrated knowledge combined with clinical judgment will enable clinicians and researchers to formulate novel hypotheses and guide their decision-making process.</p>
    <p>The current features of the tool are focused on large CNVs that intersect several genes when gene prioritization plays a role in the analysis. Future versions will increase the granularity of the tool, e.g. by providing a more detailed gene track that includes exons and introns, and different transcripts with expression data. With that, it will bring more value for interpreting intragenic deletions and duplications. Also, to integrate with existing workflows, we plan to develop an application programming interface (API) to query the system and fetch the results without using a graphical user interface. Overall, the CNV-ClinViewer is the first framework that enables interactive exploration of CNV data and semi-automated variant classification. With its scalable architecture, the web application is well suited for both genome-wide (re-)evaluations of large datasets and the small number of CNVs. The CNV-ClinViewer is an open-source tool (<ext-link xlink:href="https://www.cnv-ClinViewer.broadinstitute.org/" ext-link-type="uri">https://www.cnv-ClinViewer.broadinstitute.org/</ext-link>), including complete documentation on the use of the website.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btad290_Supplementary_Data</label>
      <media xlink:href="btad290_supplementary_data.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Author contributions</title>
    <p>Conceptualization: D.L., M.M., E.P.-P.; Data curation: M.M., E.P.-P.; Methodology: D.L., M.M., E.P.-P., P.M., M.N.; Supervision: D.L., E.P.-P.; Validation: T.B., C.K., K.P., A.S., L.M., A.B., M.R., R.L.C., D.B., J.R.L., M.T., R.S.M.; Visualization: M.M.; Writing-original draft: D.L., M.M., E.P.-P.; Writing-review and editing: P.M., M.N., E.P.-P., T.B., C.K., K.P., A.S., L.M., A.B., M.R., R.L.C., D.B., J.R.L., M.T., R.S.M.</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> is available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec>
    <title>Ethics declaration</title>
    <p>This study does not involve human subjects. We use as reference datasets copy number variants from public resources such as databases and published research studies, in which individual investigators or organizations have consented their individuals. For example, the CNV-ClinViewer contains individual copy-number variant (CNV) data from ClinVar, which is de-identified and publicly available (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>). CNV data from gnomAD (<ext-link xlink:href="https://gnomad.broadinstitute.org/downloads" ext-link-type="uri">https://gnomad.broadinstitute.org/downloads</ext-link>) and the UK Biobank (<ext-link xlink:href="https://biobankenginedev.stanford.edu/downloads" ext-link-type="uri">https://biobankenginedev.stanford.edu/downloads</ext-link>) are aggregated and de-identified data. The submitters of all databases had obtained appropriate consent for data sharing.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the German Federal Ministry for Education and Research [BMBF, Treat-ION, 01GM1907D to D.L., P.M.], and T.B. and P.M. was supported by Fonds Nationale de la Recherche in Luxembourg grants [FOR-2715, INTER/DFG/17/11583046; ProtectMove, INTER/DFG/19/14429377; NCER-PD, FNR11264123]. E.P.-P. was supported by the Chilean Agencia Nacional de Investigación y Desarrollo (ANID) grants [PAI77200124 and FONDECYT 1221464], and the FamilieSCN2A foundation 2020 Action Potential Grant.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data used in the CNV-ClinViewer are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>. All code and data are accessible at <ext-link xlink:href="https://github.com/LalResearchGroup/CNV-clinviewer" ext-link-type="uri">https://github.com/LalResearchGroup/CNV-clinviewer</ext-link>, and detailed documentation can be found at <ext-link xlink:href="https://www.cnv-ClinViewer.broadinstitute.org/" ext-link-type="uri">https://www.cnv-ClinViewer.broadinstitute.org/</ext-link>. The web application is free and open to all users, and there is no login requirement.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btad290-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aguirre</surname><given-names>M</given-names></string-name>, <string-name><surname>Rivas</surname><given-names>MA</given-names></string-name>, <string-name><surname>Priest</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>Phenome-wide burden of copy-number variation in the UK biobank</article-title>. <source>Am J Hum Genet</source><year>2019</year>;<volume>105</volume>:<fpage>373</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">31353025</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Babione</surname><given-names>JN</given-names></string-name>, <string-name><surname>Ocampo</surname><given-names>W</given-names></string-name>, <string-name><surname>Haubrich</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Human-centred design processes for clinical decision support: a pulmonary embolism case study</article-title>. <source>Int J Med Inform</source><year>2020</year>;<volume>142</volume>:<fpage>104196</fpage>.<pub-id pub-id-type="pmid">32947115</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bates</surname><given-names>DW</given-names></string-name>, <string-name><surname>Kuperman</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality</article-title>. <source>J Am Med Inform Assoc</source><year>2003</year>;<volume>10</volume>:<fpage>523</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">12925543</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B4">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Cai</surname><given-names>CJ</given-names></string-name></person-group><etal>et al</etal><year>2019</year>. Human-centered tools for coping with imperfect algorithms during medical decision-making. In: <italic toggle="yes">Proceedings of the 2019 CHI Conference on Human Factors in Computing Systems</italic>, CHI ’19, pp. <fpage>1</fpage>–<lpage>14</lpage>. Association for Computing Machinery, New York, NY, USA.</mixed-citation>
    </ref>
    <ref id="btad290-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Campbell</surname><given-names>IM</given-names></string-name>, <string-name><surname>Yatsenko</surname><given-names>SA</given-names></string-name>, <string-name><surname>Hixson</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>Novel 9q34.11 gene deletions encompassing combinations of four mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A</article-title>. <source>Genet Med</source><year>2012</year>;<volume>14</volume>:<fpage>868</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">22722545</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Collins</surname><given-names>RL</given-names></string-name>, <string-name><surname>Brand</surname><given-names>H</given-names></string-name>, <string-name><surname>Karczewski</surname><given-names>KNR J</given-names></string-name></person-group><etal>et al</etal>; <collab>Genome Aggregation Database Consortium</collab>. <article-title>A structural variation reference for medical and population genetics</article-title>. <source>Nature</source><year>2020</year>;<volume>581</volume>:<fpage>444</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">32461652</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B153">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Collins</surname><given-names>RL</given-names></string-name>, <string-name><surname>Glessner</surname><given-names>JT</given-names></string-name>, <string-name><surname>Porcu</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>A cross-disorder dosage sensitivity map of the human genome</article-title>. <source>Cell</source><year>2022</year>;<volume>185</volume>:<fpage>P3041</fpage>–<lpage>3055.E25</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2022.06.036</pub-id>.</mixed-citation>
    </ref>
    <ref id="btad290-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ehret</surname><given-names>JK</given-names></string-name>, <string-name><surname>Engels</surname><given-names>H</given-names></string-name>, <string-name><surname>Cremer</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>Microdeletions in 9q33.3-q34.11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?</article-title><source>Mol Cytogenet</source><year>2015</year>;<volume>8</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">26421060</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fan</surname><given-names>C</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>AutoCNV: a semiautomatic CNV interpretation system based on the 2019 ACMG/ClinGen technical standards for CNVs</article-title>. <source>BMC Genomics</source><year>2021</year>;<volume>22</volume>:<fpage>721</fpage>.<pub-id pub-id-type="pmid">34615484</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Firth</surname><given-names>HV</given-names></string-name>, <string-name><surname>Richards</surname><given-names>SM</given-names></string-name>, <string-name><surname>Bevan</surname><given-names>AP</given-names></string-name></person-group><etal>et al</etal><article-title>DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources</article-title>. <source>Am J Hum Genet</source><year>2009</year>;<volume>84</volume>:<fpage>524</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Geoffroy</surname><given-names>V</given-names></string-name>, <string-name><surname>Herenger</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kress</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>AnnotSV: an integrated tool for structural variations annotation</article-title>. <source>Bioinformatics</source><year>2018</year>;<volume>34</volume>:<fpage>3572</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">29669011</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Graham</surname><given-names>TAD</given-names></string-name>, <string-name><surname>Kushniruk</surname><given-names>AW</given-names></string-name>, <string-name><surname>Bullard</surname><given-names>MJ</given-names></string-name></person-group><etal>et al</etal><article-title>How usability of a Web-Based clinical decision support system has the potential to contribute to adverse medical events</article-title>. <source>AMIA Annu Symp Proc</source><year>2008</year>;<volume>2008</volume>:<fpage>257</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">18998968</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gurbich</surname><given-names>TA</given-names></string-name>, <string-name><surname>Ilinsky</surname><given-names>VV.</given-names></string-name></person-group><article-title>ClassifyCNV: a tool for clinical annotation of copy-number variants</article-title>. <source>Sci Rep</source><year>2020</year>;<volume>10</volume>:<fpage>20375</fpage>.<pub-id pub-id-type="pmid">33230148</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B154">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>N</given-names></string-name>, <string-name><surname>Lee</surname><given-names>I</given-names></string-name>, <string-name><surname>Marcotte</surname><given-names>EM</given-names></string-name></person-group><etal>et al</etal><article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <year>2010</year>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1001154</pub-id>.</mixed-citation>
    </ref>
    <ref id="btad290-B152">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karczewski</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Francioli</surname><given-names>LC</given-names></string-name>, <string-name><surname>Tiao</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature</source><year>2020</year>;<volume>581</volume>:<fpage>434</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kent</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Sugnet</surname><given-names>CW</given-names></string-name>, <string-name><surname>Furey</surname><given-names>TS</given-names></string-name></person-group><etal>et al</etal><article-title>The human genome browser at UCSC</article-title>. <source>Genome Res</source><year>2002</year>;<volume>12</volume>:<fpage>996</fpage>–<lpage>1006</lpage>.<pub-id pub-id-type="pmid">12045153</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Köhler</surname><given-names>S</given-names></string-name>, <string-name><surname>Gargano</surname><given-names>M</given-names></string-name>, <string-name><surname>Matentzoglu</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>The human phenotype ontology in 2021</article-title>. <source>Nucleic Acids Res</source><year>2021</year>;<volume>49</volume>:<fpage>D1207</fpage>–<lpage>D1217</lpage>.<pub-id pub-id-type="pmid">33264411</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuleshov</surname><given-names>MV</given-names></string-name>, <string-name><surname>Jones</surname><given-names>MR</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>AD</given-names></string-name></person-group><etal>et al</etal><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source><year>2016</year>;<volume>44</volume>:<fpage>W90</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Landrum</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JM</given-names></string-name>, <string-name><surname>Benson</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source>Nucleic Acids Res</source><year>2018</year>;<volume>46</volume>:<fpage>D1062</fpage>–<lpage>D1067</lpage>.<pub-id pub-id-type="pmid">29165669</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B151">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lek</surname><given-names>M</given-names></string-name>, <string-name><surname>Karczewski</surname><given-names>K</given-names></string-name>, <string-name><surname>Minikel</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source><year>2016</year>;<volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nambot</surname><given-names>S</given-names></string-name>, <string-name><surname>Masurel</surname><given-names>A</given-names></string-name>, <string-name><surname>El Chehadeh</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping</article-title>. <source>Eur J Hum Genet</source><year>2016</year>;<volume>24</volume>:<fpage>830</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">26395556</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nusrat</surname><given-names>S</given-names></string-name>, <string-name><surname>Harbig</surname><given-names>T</given-names></string-name>, <string-name><surname>Gehlenborg</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Tasks, techniques, and tools for genomic data visualization</article-title>. <source>Comput Graph Forum</source><year>2019</year>;<volume>38</volume>:<fpage>781</fpage>–<lpage>805</lpage>.<pub-id pub-id-type="pmid">31768085</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname><given-names>NA</given-names></string-name></person-group><etal>et al</etal><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res</source><year>2016</year>;<volume>44</volume>:<fpage>D733</fpage>–<lpage>745</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehm</surname><given-names>HL</given-names></string-name>, <string-name><surname>Berg</surname><given-names>JS</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>LD</given-names></string-name></person-group>, <collab>ClinGen</collab><etal>et al</etal><article-title>The clinical genome resource</article-title>. <source>N Engl J Med</source><year>2015</year>;<volume>372</volume>:<fpage>2235</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">26014595</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Requena</surname><given-names>F</given-names></string-name>, <string-name><surname>Abdallah</surname><given-names>HH</given-names></string-name>, <string-name><surname>García</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>CNVxplorer: a web tool to assist clinical interpretation of CNVs in rare disease patients</article-title>. <source>Nucleic Acids Res</source><year>2021</year>;<volume>49</volume>:<fpage>W93</fpage>–<lpage>W103</lpage>.<pub-id pub-id-type="pmid">34019647</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Riggs</surname><given-names>ER</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>EF</given-names></string-name>, <string-name><surname>Cherry</surname><given-names>AM</given-names></string-name></person-group><etal>et al</etal><article-title>Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American college of medical genetics and genomics (ACMG) and the clinical genome resource (ClinGen)</article-title>. <source>Genet Med</source><year>2020</year>;<volume>22</volume>:<fpage>245</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">31690835</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saitsu</surname><given-names>H</given-names></string-name>, <string-name><surname>Kato</surname><given-names>M</given-names></string-name>, <string-name><surname>Shimono</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Association of genomic deletions in the STXBP1 gene with ohtahara syndrome</article-title>. <source>Clin Genet</source><year>2012</year>;<volume>81</volume>:<fpage>399</fpage>–<lpage>402</lpage>.<pub-id pub-id-type="pmid">22211739</pub-id></mixed-citation>
    </ref>
    <ref id="btad290-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tweedie</surname><given-names>S</given-names></string-name>, <string-name><surname>Braschi</surname><given-names>B</given-names></string-name>, <string-name><surname>Gray</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>Genenames.org: the HGNC and VGNC resources in 2021</article-title>. <source>Nucleic Acids Res</source><year>2021</year>;<volume>49</volume>:<fpage>D939</fpage>–<lpage>D946</lpage>.<pub-id pub-id-type="pmid">33152070</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
